• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » GPO: Premier eyes IPO worth up to $100M

GPO: Premier eyes IPO worth up to $100M

August 27, 2013 By Arezu Sarvestani

GPO: Premier eyes IPO worth up to $100M

Premier healthcare alliance is eying an initial public offering worth up to $100 million, according to documents filed this week with the SEC. The group purchasing organization has yet to release the number of shares or the final price range for the offering.

Charlotte-based Premier noted that it had previously filed its registration documents in secret, but did not say how long the IPO had been in planning, although rumors have been flying for some time now. Premier plans to trade on the NASDAQ Capital Market under the symbol ‘PNC’.

Premier is a GPO aligning about 2,900 community hospitals and 100,000 "alternate" sites of care, encompassing some 400,000 physicians. The group generated about $869.3 million in revenue and $385.1 million in net income during fiscal 2013, according to SEC filings.

The company is currently owned by a consortium of 181 hospitals and healthcare groups, all of which will own Class B stock in the company after the IPO.

Premier, which calls itself "one of the nation’s largest performance improvement alliances," is perhaps most commonly known for its wide-ranging deals for hospital equipment and supplies. The group recently signed new contracts for drug-eluting and traditional stents with Abbott (NYSE:ABT), Boston Scientific (NYSE:BSX) and Medtronic (NYSE:MDT).

The GPO claims it provided its members with more than $5 billion in savings in fiscal 2012, and the group is a also a staple of healthcare performance improvement initiatives, including a collaboration with the Centers for Medicare & Medicaid. Premier also maintains deep data stores that in 2012 included information on 25% of U.S. patient discharges, 29% of annual hospital spending, $30 billion worth of annual direct labor expenses, 2.5 million real-time transactions every day and $40 billion in annual purchasing data, according to the SEC filing.

Following the IPO, Premier plans to restructure its business around 2 main functions: supply-chain purchasing and consulting.

Filed Under: News Well, Wall Street Beat Tagged With: Group Purchasing Organizations (GPO), Premier Inc.

More recent news

  • AdvaMed calls for medtech tariff exemptions at Senate hearing
  • GE HealthCare, Raydiant Oximetry partner on fetal oxygen saturation tech
  • Terumo Neuro launches new stroke catheter in the U.S.
  • EnVVeno has first-in-human heart valve data, expects FDA decision this year
  • Axoft makes Fleuron BCI material available for purchase, inks license deal with Stanford

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy